Clinical Trials Browser

Enrolling by invitation × Recurrence × 1 year × Clear all

Neoplasm Metastasis, Recurrence

NCT07168486 2025-09-11

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Lymphoma, Follicular, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06827782 2025-08-15

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Phase 1 Enrolling by invitation

42 enrolled

Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06931613 2025-04-17

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Phase 2 Enrolling by invitation

20 enrolled

Lymphoid

Hodgkin Disease, Recurrence

Clinical Trials

J21112LINKED

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment